Skip to main content
2024 Canadian Cardiovascular Congress Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Handout
Handout
Networking
Networking
On-Demand
On-Demand
Early Career Involvement
Early Career Involvement
Back
Session Evaluation

HEART FAILURE

SURGERY

MECHANICAL CIRCULATORY SUPPORT

CARDIOGENIC SHOCK

EARLY CAREER INVOLVEMENT

200 - CARDIOGENIC SHOCK - NOT JUST IN BIG CENTERS

Friday, October 25, 2024
7:30 AM – 8:30 AM PT
Room: 211
Early Career Involvement
Workshop Description: Cardiogenic shock is caused by severe impairment of cardiac performance that results in reduced cardiac output and end-organ hypoperfusion. Despite contemporary management of patients, the mortality remains high. Though a majority of patients present with LV failure with hypotension and end-organ malperfusion, a subset of CS patients exist which are more difficult to identify and treat.
This symposium is designed for anyone who cares for patients with suspected cardiogenic shock, from the emergency department in small communities, to large quaternary centers. We all face similar changes. We will present a clinical case followed by an multidisciplinary faculty who will highlight clinical pearls in early recognition and management strategies from the initial presentation in the field, or the emergency department, to the intensivists in specialized heart failure units.

Interactive and Engagement Activities Description: This symposium is designed to engage all members attending the Canadian Cardiovascular Congress. The session will start with a real clinical case talks on topics by national leaders in the field. Topics were chosen based on feedback from delegates at previous CCS Cardiogenic Shock Summits. Generous time will be allowed for interaction of the participants with the panel at the end of each session. Questions from the floor will also be received electronically by the moderator through the CCC app. Written feedback will be obtained from participants for planification of future CCS Cardiogenic Shock Summits.

Learning Objectives:

At the end of this session participants will be able to:
  • understand the complex pathophysiological processes in patients with cardiogenic shock.
  • understand the importance of a shock team approach to the management of patients with cardiogenic shock; and
  • apply novel concepts in the management of patients with cardiogenic shock after the initial presentation.
Disclosure(s):
Anil Gupta, MD, FRCPC: No financial relationships to disclose
Caroline M. McGuinty, MD FRCPC: Novartis: Speaker fees (Ongoing)
Faizan Amin, MD: No financial relationships to disclose
Jacinthe Boulet, MDCM, MPH: No financial relationships to disclose
Andrew Caddell, MD, MSc, FRCPC: No financial relationships to disclose
Sharon Chih, MD, PHD: No financial relationships to disclose
Chris Brian Overgaard, MD, MSc., FRCPC: No financial relationships to disclose
Lebei Pi, MD: No financial relationships to disclose
Filio Billia, MD PhD FRCPC FACC: Abbottt Laboratories: physician-initiated research funding (Ongoing)
Haley Christian, MD, MEd, FRCPC: No financial relationships to disclose
Dave Nagpal, MD, FRCSC: No financial relationships to disclose
Gurmeet Singh, MD: Abbott Medical: Honoraria (Ongoing)
Sean Van Diepen, MD FRCPC: No financial relationships to disclose